
Is the original 60-40 strategy dead?
"It's not good enough in the world that we live in now," Ian Macoun says.
"It's not good enough in the world that we live in now," Ian Macoun says.
ANZ banking exec reveals what's really happening in people's accounts.
The secretive firm - filmed for the first time - could be our next unicorn.
Sky TV, Summerset, Contact Energy and Infratil are favourites.
The European CEO of the global money transfer app talks to Madison Reidy.
China, AI and fast-moving tech: How can investors prepare?
The billionaire investor reveals what really happened at OpenAI.
ASB & BNZ want a slice of the aggressive investor. Milford CEO responds.
Billionaires and pension funds can't throw money at bonds fast enough.
"The Crown can use those funds elsewhere."
Our largest trading partner worth $40b is no longer a 'risk-free bet' for investors.
Head of the $47 billion state fund doesn't believe the AI hype.
15 years since Satoshi invented it, the digital asset is outperforming gold.
Julian Cook is 'unvarnished' in this Markets with Madison interview.
DIY investment is at "rock bottom" in the eyes of this UK billionaire.
“My two competitors are the two richest people on the planet. There’s no room for error.”
Investing giant sees five 'mega forces' at play in a 'complicated and difficult' market.
Forsyth Barr warns of a stand-off between the NZX and long-dated bond yields.
Could wine be our way out of a triple-year negative trade position?
What the leaders of Deloitte, Air New Zealand, Downer and Freightways really think.
The Warehouse Group is one major retailer suffering amid inflation.
Demand has dropped "quite substantially" as Brent crude nears US$100 a barrel.
CEO and CFO double-down on their biggest market, despite demand dropping.
Author and hedge fund advisor successfully predicted Russian coup attempt.
Why NZ power companies are undertaking a once in a generation infrastructure programme.
Exclusive: Matt Whineray talks tax and liquidity ahead of exit from $62b sovereign fund.
Goldman Sachs raises alarm on "significant income shock" for New Zealanders.
The medical device company is on a crusade against 'short-termism'.
This analyst blames bond yield rally on Biden's 'spending binge'.